HEM Pharma Inc
KOSDAQ:376270
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
Landis+Gyr Group AG
SIX:LAND
|
CH |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
La Francaise de l Energie SA
F:LFX
|
FR |
|
P
|
PostNL NV
F:TNTC
|
NL |
|
PennyMac Mortgage Investment Trust
NYSE:PMT
|
US |
|
P
|
Prada SpA
XMUN:PRP
|
IT |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de HEM Pharma Inc.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace HEM Pharma
HEM Pharma, Inc. engages in the provision of microbiome solutions. The company is headquartered in Suwon, Gyeonggi-Do and currently employs 101 full-time employees. The company went IPO on 2024-11-05. The firm mainly operates two businesses. The customized healthcare services business mainly researching and discovery the relationship between diseases and human body’s various microbiota and beneficial substances produced by microorganisms to provide the optimal solution for individuals.
- Sede central
- Corea KR
- Empleados
- 63
- Fecha de salida a bolsa
- 5 nov., 2024